Ascent Wealth Partners’s ResMed RMD Stock Holding History

Ascent Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.17M	Buy	14,135 +624	+5%	+$156K	0.37%	69
2025 Q4	$3.25M	Buy	13,511 +213	+2%	+$54.5K	0.37%	64
2025 Q3	$3.64M	Buy	13,298 +163	+1%	+$44.5K	0.42%	59
2025 Q2	$3.39M	Sell	13,135 -151	-1%	-$36K	0.42%	62
2025 Q1	$2.97M	Buy	13,286 +408	+3%	+$95.2K	0.4%	58
2024 Q4	$2.95M	Sell	12,878 -40	-0.3%	-$9.63K	0.4%	56
2024 Q3	$3.15M	Sell	12,918 -68	-0.5%	-$15.2K	0.44%	55
2024 Q2	$2.49M	Buy	12,986 +6,083	+88%	+$1.23M	0.36%	58
2024 Q1	$1.37M	Buy	+6,903	New	+$1.26M	0.2%	95

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ascent Wealth Partners's RMD Position: Q1 2026 in Review

Ascent Wealth Partners increased its ResMed (RMD) stake by 4.6% in Q1 2026, buying an estimated $156K and bringing the position to 14,135 shares worth $3.17M. The position accounts for 0.37% of the portfolio, ranked #69.

Ascent Wealth Partners first reported a position in RMD in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.64M in Q3 2025. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

Ascent Wealth Partners held 14,135 shares of ResMed worth $3.17M as of Q1 2026.
Ascent Wealth Partners bought 624 ResMed shares in Q1 2026, an estimated $156K.
ResMed made up 0.37% of Ascent Wealth Partners's portfolio in Q1 2026, its #69 holding.
Ascent Wealth Partners first reported a position in ResMed in Q1 2024 and has held it in 9 quarters since.
Ascent Wealth Partners's ResMed position peaked at $3.64M in Q3 2025.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Ascent Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.